Articles

How dealmaking may jumpstart CGT development again

Jan. 6, 2025
Contrasting the fortunes of other hot drug classes, it is possible that cell and gene therapies may have reached their apex. So, where do they go next?

Editor’s (re)View: US investment in biomanufacturing needed amid challenge from China

Jan. 3, 2025
With China aggressively pursuing a strategy to become the world’s leader in biotech, America must invest in biomanufacturing to maintain its global dominance.

Editor’s (re)View: China and India dominate this week’s pharma manufacturing news

Dec. 27, 2024
The week’s biggest announcement was WuXi AppTec’s sale of WuXi Advanced Therapies, its cell and gene therapy unit, to U.S.-based private equity firm Altaris.

Building a more resilient biopharma supply chain in 2025

Dec. 26, 2024
The biopharmaceutical industry’s supply chain will again be strained. Here’s how the sector could build more resiliency.

Cell and gene therapy manufacturing challenges to persist in 2025

Dec. 23, 2024
As potentially curative therapies, CGTs offer hope to millions of patients but remain complex and difficult to manufacture at scale.

Editor’s (re)View: Novo Holdings’ $16.5B Catalent buyout is the top pharma manufacturing story of 2024

Dec. 20, 2024
The acquisition, which took the global contract development and manufacturing organization private, is a one-off the likes of which the industry will not see again.

CDMO sector looks to recovery in 2025 amid positive macro, industry trends

Dec. 19, 2024
Though 2024 was a “mixed bag” for contract development and manufacturing organizations, a rosier picture is emerging for next year.

How regulatory dossier generation with GenAI offers a solution to compliance complexity

Dec. 13, 2024
It may only be a matter of time until pharma companies will be able to defer to the technology for entire submissions creation

Data partnerships are central for integrating AI in CGT manufacturing

Dec. 13, 2024
There remains huge untapped potential to increase efficiency in manufacturing and improve outcomes, and nowhere is that more pressing than for cell and gene therapies (CGTs). ...

Editor’s (re)View: BIOSECURE Act hits legislative roadblock with passage in question

Dec. 13, 2024
The proposed legislation, which prevents U.S. federal funds from supporting certain Chinese contract manufacturers, was omitted from a defense bill leaving its fate in limbo.

Key drugs losing patent protection in 2025

Dec. 12, 2024
From life-saving diabetes medications to essential respiratory treatments, several high-profile drugs will lose their patent exclusivity next year.

Improving sustainability in pharma cold chain

Dec. 9, 2024
Drugmakers are tackling sustainability challenges to ensure energy efficiency and reduced environmental impact

Editor’s (re)View: Big Pharma doubles down on manufacturing investments

Dec. 6, 2024
This week, drug manufacturers — including Amgen, Eli Lilly, Novo Nordisk and Sanofi — announced plans to expand their production footprints in the U.S., Europe and Asia.

Advancing preclinical research with virtual control groups

Dec. 5, 2024
The future of non-clinical research may depend on integrating VCGs for a more humane and efficient approach.

The top 4 of 2024

Nov. 19, 2024
A rundown of 2024’s defining pharma moments, from game-changing therapies to billion-dollar deals.

Editors' (re)View: Trump nominates RFK Jr. for health and human services

Nov. 15, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of November 11

Defining zero emissions buildings

Nov. 14, 2024
By embracing this standard, pharma facilities can create healthier, more sustainable buildings while contributing to a net-zero future

10 things to know about the Drug Supply Chain Security Act

Nov. 12, 2024
Here are the top things you need to know about the DSCSA, its implications, and how you can ensure your healthcare facility is compliant

The value of asset maintenance

Nov. 8, 2024
How proactive maintenance safeguards quality, compliance, and reputation in pharmaceuticals.

Raising the bar

Nov. 8, 2024
This year’s Pharma Innovation Awards are setting new standards and quietly reshaping the future of pharma manufacturing

The evolution of Pharma 4.0

Nov. 8, 2024
Despite notable progress in recent years, few organizations have fully leveraged a Pharma 4.0 strategy to its maximum potential.

Leveraging workflows with AI

Nov. 6, 2024
How AI-inclusive advanced analytics platforms can enhance daily workflows by facilitating data collection, centralization and sharing

Going above and beyond

Nov. 4, 2024
This year’s Pharma Innovation Awards are creating tools that elevate precision and efficiency in every step of the drug manufacturing process.

Securing the supply chain through workforce empowerment

Oct. 29, 2024
How making the most of your operations team can stabilize drug production

Pittsburgh’s biotech leap

Oct. 28, 2024
Building on its manufacturing legacy, Pittsburgh is now headed in a new direction — from steel to science

Editors' (re)View: J&J's third bankruptcy bid faces DOJ pushback

Oct. 25, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of October 21

The key to future-proofing drug manufacturing and speeding QC

Oct. 24, 2024
How to harness lab automation to create a seamless workflow and streamline drug testing processes.

A look at DSCSA exemptions

Oct. 23, 2024
The FDA recently granted exemptions from certain Drug Supply Chain Security Act (DSCSA) requirements to eligible trading partners facing challenges with data exchange. These exemptions...

Editors' (re)View: AbbVie's Parkinson's drug approved, finally 

Oct. 18, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of October 14

A new look at quality control from the latest X-ray technology

Oct. 15, 2024
With the annual global use of medicines predicted to reach $3.8 trillion defined daily doses by 20281, technology has a key role to play in helping pharma manufacturers ensure...